<p>根據 Regal Partners Ltd 最近向證券交易委員會提交的文件，該公司在第三季度購買了 Inspire Medical Systems, Inc.（紐約證券交易所代碼：INSP - 免費報告）的新股份。該公司購買了 101,714 股該公司的股票，價值約為 7,547,000 美元。Inspire Medical Systems 佔 Regal Partners Ltd 投資組合的約 0.5%，使其成為該公司第 26 大持倉。截至最近向證券交易委員會提交的文件，Regal Partners Ltd 持有 Inspire Medical Systems 的 0.35%。</p>
<ul>
<li>艾利 Lilly 股票上漲：GLP-1 Zepbound 目標睡眠呼吸暫停市場</li>
</ul>
<p>其他機構投資者最近也買賣了該公司的股票。德克薩斯州永久學校基金公司在第二季度將其在 Inspire Medical Systems 的股份增加了 42.2%。德克薩斯州永久學校基金公司現在擁有 40,042 股該公司的股票，價值 5,196,000 美元，在此期間又收購了 11,892 股。Y Intercept Hong Kong Ltd 在第三季度將其在 Inspire Medical Systems 的股份增加了 553.1%。Y Intercept Hong Kong Ltd 現在擁有 99,049 股該公司的股票，價值 7,349,000 美元，在此期間又收購了 83,883 股。CW Advisors LLC 在第二季度將其在 Inspire Medical Systems 的股份增加了 45.3%。CW Advisors LLC 現在擁有 49,960 股該公司的股票，價值 6,484,000 美元，在此期間又收購了 15,576 股。Capital Fund Management S.A.在第二季度將其在 Inspire Medical Systems 的持股增加了 44.1%。Capital Fund Management S.A.現在擁有 68,663 股該公司的股票，價值 8,910,000 美元，在上個季度又購買了 21,021 股。最後，挪威銀行在第二季度收購了 Inspire Medical Systems 的新股份，價值 31,066,000 美元。機構投資者和對沖基金持有該公司 94.91% 的股票。</p>
<h2>Inspire Medical Systems 股票表現</h2>
<p>INSP 股票在週五開盤價為 63.01 美元。Inspire Medical Systems, Inc.的 52 周低點為 53.11 美元，52 周高點為 189.49 美元。該公司的市值為 18 億美元，市盈率為 12.65，市盈率增長比率為 3.09，貝塔值為 0.74。該公司的 50 日簡單移動平均線為 77.16 美元，200 日簡單移動平均線為 87.18 美元。</p>
<ul>
<li>Inspire Medical 在突破後上漲 15%，分析師稱其為買入</li>
</ul>
<p>Inspire Medical Systems（紐約證券交易所代碼：INSP - 獲取免費報告）最近在 2 月 11 日星期三發佈了季度財報。該公司報告每股收益為 1.65 美元，超出市場共識預期的 0.69 美元，超出 0.96 美元。該公司在該季度的收入為 2.6908 億美元，而分析師預期為 2.6402 億美元。Inspire Medical Systems 的淨利潤率為 15.95%，股本回報率為 10.96%。該公司的收入同比增長 12.2%。在去年同期，該公司每股收益為 1.15 美元。分析師預計 Inspire Medical Systems, Inc.在當前年度將發佈 2.16 美元的每股收益。</p>
<h2>分析師評級變動</h2>
<p>幾位股票分析師對 INSP 股票發表了評論。摩根士丹利在 2 月 18 日星期三的報告中對 Inspire Medical Systems 的股票設定了 60.00 美元的目標價。Oppenheimer 在 1 月 22 日星期四的報告中將 Inspire Medical Systems 的股票評級從 “跑贏大盤” 下調至 “市場表現”。Weiss Ratings 在 12 月 29 日星期一的研究報告中重申了對 Inspire Medical Systems 的 “賣出（d）” 評級。Stifel Nicolaus 在週四的研究報告中將 Inspire Medical Systems 的目標價從 95.00 美元下調至 85.00 美元，並對該公司設定了 “買入” 評級。最後，富國銀行在 2 月 12 日星期四的研究報告中對 Inspire Medical Systems 設定了 70.00 美元的目標價，並給予該公司 “等權重” 評級。五位投資分析師對該股票給予了買入評級，十三位給予了持有評級，一位給予了賣出評級。根據 MarketBeat.com 的數據，該股票目前的平均評級為 “持有”，共識目標價為 104.24 美元。</p>
<ul>
<li>小型股是否預示市場下跌？</li>
</ul>
<p><strong>查看我們關於 INSP 的最新報告</strong></p>
<h2>關於 Inspire Medical Systems</h2>
<p>（免費報告）</p>
<p>Inspire Medical Systems, Inc 是一家醫療技術公司，專注於用於治療阻塞性睡眠呼吸暫停（OSA）的可植入神經刺激設備。該公司的旗艦產品 Inspire®系統，通過對舌下神經的定向刺激，保持睡眠期間氣道通暢，為對持續正壓呼吸機（CPAP）設備不耐受或管理不當的患者提供替代療法。</p>
<p>Inspire 系統由一個可植入的脈衝發生器、一個監測呼吸模式的傳感導線和一個激活舌下神經的刺激導線組成。</p>
<h2>另見</h2>
<ul>
<li>五隻我們更看好的股票，勝過 Inspire Medical Systems</li>
<li>摩根大通 8000 美元的黃金看漲期權將使大多數退休賬户落後</li>
<li>白銀是新的石油——世界正在枯竭</li>
<li>英偉達首席執行官發出大膽的特斯拉呼籲</li>
<li>埃隆的最大突破？</li>
<li>這讓我感到憤怒</li>
</ul>
<p><strong>想看看其他對沖基金持有 INSP 的情況嗎？</strong> 訪問 HoldingsChannel.com，獲取 Inspire Medical Systems, Inc.（紐約證券交易所代碼：INSP - 免費報告）的最新 13F 文件和內部交易信息。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUlOU1A?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUlOU1A"/></p>
<p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1000 美元在 Inspire Medical Systems 嗎？</h2>
<p>在考慮 Inspire Medical Systems 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已經識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而啓迪醫療並不在名單上。</p>
<p>雖然啓迪醫療目前在分析師中被評為持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

標普生物技術 ETF - SPDR

動態生物技術與基因組 ETF - Invesco

2 倍做多納斯達克生物技術 ETF - ProShares

紐交所高增長板生物技術指數 ETF - First Trust

醫藥突破 ETF - ALPS

啟迪醫療

生物科技 ETF - VanEck Vectors

納斯達克生物科技指數 ETF - iShares Nasdaq

美國醫藥設備 ETF - iShares

標普健康醫療設備 ETF - SPDR

<p>Regal Partners Ltd 已在 Inspire Medical Systems, Inc.（紐約證券交易所代碼：INSP）中獲得了一個新頭寸，購買了 101,714 股，價值約 750 萬美元，使其成為該投資組合中第 26 大的頭寸。其他機構投資者也增加了對 Inspire Medical Systems 的持股。該公司的股票開盤價為 63.01 美元，市值為 18 億美元，市盈率為 12.65。分析師對該股票的評級不一，平均評級為 “持有”，共識目標價為 104.24 美元</p>

<p>Regal Partners Ltd purchased a new position in shares of Inspire Medical Systems, Inc. (NYSE:INSP - Free Report) in the third quarter, according to the company in its most recent filing with the Securities &amp; Exchange Commission. The firm purchased 101,714 shares of the company's stock, valued at approximately $7,547,000. Inspire Medical Systems accounts for approximately 0.5% of Regal Partners Ltd's investment portfolio, making the stock its 26th largest position. Regal Partners Ltd owned 0.35% of Inspire Medical Systems as of its most recent filing with the Securities &amp; Exchange Commission.</p>
<div class="lb-trans"><p>根據 Regal Partners Ltd 最近向證券交易委員會提交的文件，該公司在第三季度購買了 Inspire Medical Systems, Inc.（紐約證券交易所代碼：INSP - 免費報告）的新股份。該公司購買了 101,714 股該公司的股票，價值約為 7,547,000 美元。Inspire Medical Systems 佔 Regal Partners Ltd 投資組合的約 0.5%，使其成為該公司第 26 大持倉。截至最近向證券交易委員會提交的文件，Regal Partners Ltd 持有 Inspire Medical Systems 的 0.35%。</p>
</div><ul>
<li>Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market</li>
</ul>
<div class="lb-trans"><ul>
<li>艾利 Lilly 股票上漲：GLP-1 Zepbound 目標睡眠呼吸暫停市場</li>
</ul>
</div><p>Other institutional investors have also recently bought and sold shares of the company. Texas Permanent School Fund Corp boosted its stake in shares of Inspire Medical Systems by 42.2% during the 2nd quarter. Texas Permanent School Fund Corp now owns 40,042 shares of the company's stock worth $5,196,000 after acquiring an additional 11,892 shares during the period. Y Intercept Hong Kong Ltd raised its stake in Inspire Medical Systems by 553.1% in the 3rd quarter. Y Intercept Hong Kong Ltd now owns 99,049 shares of the company's stock valued at $7,349,000 after acquiring an additional 83,883 shares during the period. CW Advisors LLC raised its stake in Inspire Medical Systems by 45.3% in the 2nd quarter. CW Advisors LLC now owns 49,960 shares of the company's stock valued at $6,484,000 after acquiring an additional 15,576 shares during the period. Capital Fund Management S.A. lifted its holdings in Inspire Medical Systems by 44.1% during the 2nd quarter. Capital Fund Management S.A. now owns 68,663 shares of the company's stock valued at $8,910,000 after purchasing an additional 21,021 shares during the last quarter. Finally, Norges Bank acquired a new stake in Inspire Medical Systems during the 2nd quarter valued at $31,066,000. Institutional investors and hedge funds own 94.91% of the company's stock.</p>
<div class="lb-trans"><p>其他機構投資者最近也買賣了該公司的股票。德克薩斯州永久學校基金公司在第二季度將其在 Inspire Medical Systems 的股份增加了 42.2%。德克薩斯州永久學校基金公司現在擁有 40,042 股該公司的股票，價值 5,196,000 美元，在此期間又收購了 11,892 股。Y Intercept Hong Kong Ltd 在第三季度將其在 Inspire Medical Systems 的股份增加了 553.1%。Y Intercept Hong Kong Ltd 現在擁有 99,049 股該公司的股票，價值 7,349,000 美元，在此期間又收購了 83,883 股。CW Advisors LLC 在第二季度將其在 Inspire Medical Systems 的股份增加了 45.3%。CW Advisors LLC 現在擁有 49,960 股該公司的股票，價值 6,484,000 美元，在此期間又收購了 15,576 股。Capital Fund Management S.A.在第二季度將其在 Inspire Medical Systems 的持股增加了 44.1%。Capital Fund Management S.A.現在擁有 68,663 股該公司的股票，價值 8,910,000 美元，在上個季度又購買了 21,021 股。最後，挪威銀行在第二季度收購了 Inspire Medical Systems 的新股份，價值 31,066,000 美元。機構投資者和對沖基金持有該公司 94.91% 的股票。</p>
</div><h2>Inspire Medical Systems Stock Performance</h2>
<div class="lb-trans"><h2>Inspire Medical Systems 股票表現</h2>
</div><p>INSP stock opened at $63.01 on Friday. Inspire Medical Systems, Inc. has a 52 week low of $53.11 and a 52 week high of $189.49. The company has a market capitalization of $1.80 billion, a PE ratio of 12.65, a price-to-earnings-growth ratio of 3.09 and a beta of 0.74. The company's 50-day simple moving average is $77.16 and its 200 day simple moving average is $87.18.</p>
<div class="lb-trans"><p>INSP 股票在週五開盤價為 63.01 美元。Inspire Medical Systems, Inc.的 52 周低點為 53.11 美元，52 周高點為 189.49 美元。該公司的市值為 18 億美元，市盈率為 12.65，市盈率增長比率為 3.09，貝塔值為 0.74。該公司的 50 日簡單移動平均線為 77.16 美元，200 日簡單移動平均線為 87.18 美元。</p>
</div><ul>
<li>Inspire Medical Up 15% After Breakout, Analysts Say It's A Buy</li>
</ul>
<div class="lb-trans"><ul>
<li>Inspire Medical 在突破後上漲 15%，分析師稱其為買入</li>
</ul>
</div><p>Inspire Medical Systems (NYSE:INSP - Get Free Report) last issued its quarterly earnings data on Wednesday, February 11th. The company reported $1.65 earnings per share for the quarter, topping the consensus estimate of $0.69 by $0.96. The business had revenue of $269.08 million during the quarter, compared to analysts' expectations of $264.02 million. Inspire Medical Systems had a net margin of 15.95% and a return on equity of 10.96%. The business's revenue was up 12.2% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.15 EPS. On average, analysts forecast that Inspire Medical Systems, Inc. will post 2.16 EPS for the current year.</p>
<div class="lb-trans"><p>Inspire Medical Systems（紐約證券交易所代碼：INSP - 獲取免費報告）最近在 2 月 11 日星期三發佈了季度財報。該公司報告每股收益為 1.65 美元，超出市場共識預期的 0.69 美元，超出 0.96 美元。該公司在該季度的收入為 2.6908 億美元，而分析師預期為 2.6402 億美元。Inspire Medical Systems 的淨利潤率為 15.95%，股本回報率為 10.96%。該公司的收入同比增長 12.2%。在去年同期，該公司每股收益為 1.15 美元。分析師預計 Inspire Medical Systems, Inc.在當前年度將發佈 2.16 美元的每股收益。</p>
</div><h2>Analyst Ratings Changes</h2>
<div class="lb-trans"><h2>分析師評級變動</h2>
</div><p>Several equities analysts have commented on INSP shares. Morgan Stanley set a $60.00 price objective on shares of Inspire Medical Systems in a report on Wednesday, February 18th. Oppenheimer downgraded shares of Inspire Medical Systems from an &#34;outperform&#34; rating to a &#34;market perform&#34; rating in a report on Thursday, January 22nd. Weiss Ratings reiterated a &#34;sell (d)&#34; rating on shares of Inspire Medical Systems in a research note on Monday, December 29th. Stifel Nicolaus cut their price objective on shares of Inspire Medical Systems from $95.00 to $85.00 and set a &#34;buy&#34; rating for the company in a research report on Thursday. Finally, Wells Fargo &amp; Company set a $70.00 target price on Inspire Medical Systems and gave the company an &#34;equal weight&#34; rating in a research report on Thursday, February 12th. Five investment analysts have rated the stock with a Buy rating, thirteen have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock currently has an average rating of &#34;Hold&#34; and a consensus price target of $104.24.</p>
<div class="lb-trans"><p>幾位股票分析師對 INSP 股票發表了評論。摩根士丹利在 2 月 18 日星期三的報告中對 Inspire Medical Systems 的股票設定了 60.00 美元的目標價。Oppenheimer 在 1 月 22 日星期四的報告中將 Inspire Medical Systems 的股票評級從 “跑贏大盤” 下調至 “市場表現”。Weiss Ratings 在 12 月 29 日星期一的研究報告中重申了對 Inspire Medical Systems 的 “賣出（d）” 評級。Stifel Nicolaus 在週四的研究報告中將 Inspire Medical Systems 的目標價從 95.00 美元下調至 85.00 美元，並對該公司設定了 “買入” 評級。最後，富國銀行在 2 月 12 日星期四的研究報告中對 Inspire Medical Systems 設定了 70.00 美元的目標價，並給予該公司 “等權重” 評級。五位投資分析師對該股票給予了買入評級，十三位給予了持有評級，一位給予了賣出評級。根據 MarketBeat.com 的數據，該股票目前的平均評級為 “持有”，共識目標價為 104.24 美元。</p>
</div><ul>
<li>Are Small Caps a Harbinger of Market Declines?</li>
</ul>
<div class="lb-trans"><ul>
<li>小型股是否預示市場下跌？</li>
</ul>
</div><p><strong>Check Out Our Latest Report on INSP</strong></p>
<div class="lb-trans"><p><strong>查看我們關於 INSP 的最新報告</strong></p>
</div><h2>About Inspire Medical Systems</h2>
<div class="lb-trans"><h2>關於 Inspire Medical Systems</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免費報告）</p>
</div><p>Inspire Medical Systems, Inc is a medical technology company specializing in implantable neurostimulation devices for the treatment of obstructive sleep apnea (OSA). The company's flagship offering, the Inspire® system, delivers targeted stimulation of the hypoglossal nerve to maintain airway patency during sleep, providing an alternative therapy for patients who are intolerant of or inadequately managed by continuous positive airway pressure (CPAP) devices.</p>
<div class="lb-trans"><p>Inspire Medical Systems, Inc 是一家醫療技術公司，專注於用於治療阻塞性睡眠呼吸暫停（OSA）的可植入神經刺激設備。該公司的旗艦產品 Inspire®系統，通過對舌下神經的定向刺激，保持睡眠期間氣道通暢，為對持續正壓呼吸機（CPAP）設備不耐受或管理不當的患者提供替代療法。</p>
</div><p>The Inspire system comprises an implantable pulse generator, a sensing lead that monitors breathing patterns, and a stimulation lead that activates the hypoglossal nerve.</p>
<div class="lb-trans"><p>Inspire 系統由一個可植入的脈衝發生器、一個監測呼吸模式的傳感導線和一個激活舌下神經的刺激導線組成。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另見</h2>
</div><ul>
<li>Five stocks we like better than Inspire Medical Systems</li>
<li>How JPMorgan's $8,000 Gold Call Will Leave Most Retirement Accounts Behind</li>
<li>Silver Is the New Oil—And the World’s Running Dry</li>
<li>Nvidia CEO Issues Bold Tesla Call</li>
<li>Elon’s BIGGEST breakthrough yet?</li>
<li>This makes me furious</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票，勝過 Inspire Medical Systems</li>
<li>摩根大通 8000 美元的黃金看漲期權將使大多數退休賬户落後</li>
<li>白銀是新的石油——世界正在枯竭</li>
<li>英偉達首席執行官發出大膽的特斯拉呼籲</li>
<li>埃隆的最大突破？</li>
<li>這讓我感到憤怒</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding INSP?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Inspire Medical Systems, Inc. (NYSE:INSP - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他對沖基金持有 INSP 的情況嗎？</strong> 訪問 HoldingsChannel.com，獲取 Inspire Medical Systems, Inc.（紐約證券交易所代碼：INSP - 免費報告）的最新 13F 文件和內部交易信息。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUlOU1A" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=INSP"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Inspire Medical Systems Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1000 美元在 Inspire Medical Systems 嗎？</h2>
</div><p>Before you consider Inspire Medical Systems, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Inspire Medical Systems 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Inspire Medical Systems wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已經識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而啓迪醫療並不在名單上。</p>
</div><p>While Inspire Medical Systems currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然啓迪醫療目前在分析師中被評為持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Regal Partners Ltd Buys New Holdings in Inspire Medical Systems, Inc. $INSP

Market Beat

Regal Partners Ltd 購入了啓迪醫療系統公司（Inspire Medical Systems, Inc.）的新股份 $INSP